ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2570

Comparative Analysis of Collagen-Antibody Induced Arthritis and the  Arthritis Inhibitory Potential of Specific ACPA in Two Mouse Subspecies Genetically Separated about One Million Years Ago

Christina Grimm1, Bianka Marklein1, Zoltan Konthur2, Gerd Burmester1 and Karl Skriner1, 1Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany, 2Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: ACPA, autoantibodies, Collagen, mouse model and toll-like receptors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Animal Models Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid arthritis (RA) is believed to be induced by environmental, genetic and immunological factors. Monoclonal Anti-citrullinated protein/peptide autoantibodies (ACPA) target different citrullinated proteins years before RA is diagnosed but their role is still largely unknown. As a prerequisite to identify genetic factors involved in rheumatoid arthritis, we analyzed the susceptibility of PWD Mus musculus musculus subspecies, separated from Mus musculus domesticus about one million years ago to collagen antibody-induced arthritis (CAIA) and the role of ACPA antibodies in the CAIA model of arthritis.

Methods:

Collagen antibody-induced arthritis (CAIA antibody cocktail provided by Modiquest GmbH) was induced by administration of collagen antibodies followed by lipopolysaccharide injection. Two genetically distinct mouse strains, representatives of the subspecies Mus musculus domesticus and Mus musculus musculus as well as their F1 hybrids, and consomis strains thereof were analyzed for the development of clinical and histological signs of arthritis upon CAIA treatment. ACPA antibodies were tested by adding it to the CAIA cocktail and their autoantigenic profile was analysed using protein macroarrays as previously described (Leidinger et al., 2009)

Results:

The wild-derived mouse strain PWD/Ph was highly susceptible to CAIA induced arthritis, whereas the classical laboratory strain C57BL/6J was resistant ( 2mg CAIA cocktail). Mice carrying chromosomes 5 or 12 from PWD on a B6 background display a B6-like phenotype in the CAIA model as well as the F1 hybrids (B6xPWD and PWDxB6) implicating the presence of dominant resistance modifiers in the C57BL/6J genetic background. The two mouse strains differ highly in their autoantigenic profile induced and the PWD strain shows decrease of B-cells and IgA, IgG, IgM levels.

Injecting specific monoclonal ACPAs reactive with the citrullintated H1 and H4 were able to block the CAIA induced arthritis. This inhibition can be explained in part by a Toll dependent inhibition of osteoclasts. Moreover we show the first time that TLR2 activation via Porphyromonas gingivalis LPS or vesicles and lipomannan treated animals show a 80% reduction of arthritis score compared to E. coli LPS in a C57BL/6J CAIA model.

Anti-collagen specific antibodies are increased in both strains B6 and PWD when arthritis is induced. Rheumatoid factor RF was not detected in PWD or B6 mice before and after the CAIA-treatment nor in the LPS-treated control animals. Interestingly, the commercial CCP2 ELISA detected ACPA in some animals regardless of the treatment. Using the arginine and citrulline containing peptides as control shows that this response is directed to the arginine containing peptide and in most of the animals citrullination downregulates the antigenicity of the autoantibody targeting of uncitrullinated proteins or peptides.

Conclusion:

The Mus musculus musculus derived mouse strain PWD/Ph is a highly susceptible CAIA mouse strain to study new genetic arthritis markers. TLR2 activation of P. gingivalis LPS blocks CAIA and specific ACPAs inhibit osteoclast activation and may be used as therapeutic antibodies in the future that protect from RA destructive development.


Disclosure: C. Grimm, None; B. Marklein, None; Z. Konthur, None; G. Burmester, None; K. Skriner, None.

To cite this abstract in AMA style:

Grimm C, Marklein B, Konthur Z, Burmester G, Skriner K. Comparative Analysis of Collagen-Antibody Induced Arthritis and the  Arthritis Inhibitory Potential of Specific ACPA in Two Mouse Subspecies Genetically Separated about One Million Years Ago [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/comparative-analysis-of-collagen-antibody-induced-arthritis-and-the-arthritis-inhibitory-potential-of-specific-acpa-in-two-mouse-subspecies-genetically-separated-about-one-million-years-ago/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparative-analysis-of-collagen-antibody-induced-arthritis-and-the-arthritis-inhibitory-potential-of-specific-acpa-in-two-mouse-subspecies-genetically-separated-about-one-million-years-ago/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology